Completed NA INTERVENTIONAL 3-arm NCT04972630

R21 India Pal-Care Evaluation

Implementation of Home-Based Palliative Care in Limited Resource Settings

Sponsor: Medical University of South Carolina

Interventions Control-Usual Care Pal-Care

Updated 7 times since 2021 Last updated: Nov 18, 2024 Started: Nov 1, 2021 Primary completion: Jul 31, 2023 Completion: Jul 31, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Cancer Palliative Care, this trial is completed. The trial is conducted by Medical University of South Carolina and has accumulated 7 data snapshots since 2021. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

7 versions recorded

Dec 2024 — Present [monthly]

Completed NA

Status: Unknown → Completed
Sep 2024 — Dec 2024 [monthly]

Unknown NA
Aug 2024 — Sep 2024 [monthly]

Unknown NA

Status: Recruiting → Unknown
Jul 2024 — Aug 2024 [monthly]

Recruiting NA
Sep 2022 — Jul 2024 [monthly]

Recruiting NA

▶ Show 2 earlier versions

Dec 2021 — Sep 2022 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Sep 2021 — Dec 2021 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medical University of South Carolina
National Cancer Institute (NCI)
Tata Medical Center

Data source: Medical University of South Carolina

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kolkata, India